COMMUNIQUÉS West-GlobeNewswire

Iovance Biotherapeutics Expands Pipeline of TIL Therapies into Lung Cancer

13/12/2017 - 13:00

Moffitt Cancer Center Phase 1 Study Combining TIL and Nivolumab Initiated in NSCLC Patients Iovance/MedImmune Clinical Collaboration to Initiate with Start of Phase 2 Study in PD-1/PDL-1 Naïve NSCLC Patients 1H 2018 SAN [...]

GW Pharmaceuticals Reacquires Full Rights to Develop and Commercialize Sativex® in U.S.

13/12/2017 - 13:00

LONDON, Dec. 13, 2017 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH ) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its [...]

National Research Corporation Announces Revised Class B Common Stock Recapitalization Plan

13/12/2017 - 13:00

All class B shares to be exchanged for one share of class A common stock plus $19.59 in cash, for total value of $53.44 per class B share Class A common stock to be sole outstanding security of the Company Previously [...]

Q Therapeutics Announces Research Collaboration With REPROCELL

13/12/2017 - 13:00

SALT LAKE CITY and YOKOHAMA, Japan, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Q Therapeutics, Inc., a developer of clinical-stage cell therapies for central nervous system (CNS) disease and injury, announced a collaborative [...]

Natus to Present at J.P. Morgan 36th Annual Healthcare Conference

13/12/2017 - 13:00

PLEASANTON, Calif., Dec. 13, 2017 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: BABY ) today announced that Jim Hawkins, President and Chief Executive Officer will present and Jonathan Kennedy, Executive Vice [...]

argenx announces size of proposed public offering in the United States updated to 3.5 million ADSs

13/12/2017 - 12:00

Regulated information - Inside information December 13, 2017 Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX) a clinical-stage biotechnology company developing a deep pipeline of [...]

Photocure ASA: Presentation at the DNB Nordic Healthcare Conference, Oslo

13/12/2017 - 10:56

Oslo, Norway, December 13, 2017 - Photocure ASA (OSE: PHO) announces today that the company will present at the DNB Nordic Healthcare Conference on 14th of December 2017 in Oslo, Norway. Presenter will be Ambaw Bellete [...]

CORRECTION: Valerijs Maligins, Chairman of the Board of AS Olainfarm Has Passed Away - date changed

13/12/2017 - 09:35

Olaine, 2017-12-13 09:35 CET (GLOBE NEWSWIRE) -- Valerijs Maligins became Chairman of Olainfarm’s Board after the privatization of the company in 1997. Under his management, the company became one of the most valuable [...]

Update on C-RAD delivery of its advanced surface tracking solution to Swedish Cancer Center Nya Karolinska Solna

13/12/2017 - 08:30

C-RAD announced in August that a contract to supply Nya Karolinska Solna (NKS) and Södersjukhuset in Stockholm, Sweden with its latest SIGRT (Surface Image Guided Radiation Therapy) solution was signed with Elekta [...]

Nexstim Plc's Financial Information in 2018

13/12/2017 - 08:01

Company announcement, Helsinki, 13 December 2017, at 9 am Nexstim Plc (NXTMH:HEX, NXTMS:STO) (" Nexstim " or the " Company "), a medical technology company developing and marketing pioneering navigated non-invasive [...]

Sanofi : Sanofi presents R&D strategy and innovative pipeline

13/12/2017 - 07:16

Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi presents R&D strategy and innovative pipeline · Robust pipeline expected to support long-term growth · 9 planned regulatory submissions over next 18 [...]

Sanofi : Sanofi présente sa stratégie de R&D et son portefeuille innovant

13/12/2017 - 07:16

Sanofi présente sa stratégie de R&D et son portefeuille innovant · Un portefeuille robuste qui devrait soutenir la croissance à long terme · Neuf soumissions réglementaires planifiées au cours des 18 prochains mois [...]

Sanofi and Regeneron announce positive topline pivotal results for PD-1 antibody cemiplimab in advanced cutaneous squamous cell carcinoma

13/12/2017 - 07:02

Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi and Regeneron announce positive topline pivotal results for PD-1 antibody cemiplimab in advanced cutaneous squamous cell carcinoma High and durable [...]

Sanofi et Regeneron annoncent les premiers résultats positifs d'une étude pivot consacrée à l'anticorps anti-PD-1 cemiplimab dans le traitement du carcinome épidermoïde cutané au stade avancé

13/12/2017 - 07:02

Communiqué de presse Source : Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi et Regeneron annoncent les premiers résultats positifs d'une étude pivot consacrée à l'anticorps anti-PD-1 cemiplimab dans le traitement du [...]

Targovax to present at DNB healthcare conference

13/12/2017 - 07:00

Oslo, Norway, 13 December 2017 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, announces that members of its senior management will present a [...]

Resverlogix Announces Voting Results From The 2017 Annual Meeting Of Shareholders

13/12/2017 - 02:08

CALGARY, Alberta, Dec. 12, 2017 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix”, or the "Corporation") (TSX: RVX ) announced today that, at its annual meeting of shareholders held on December 12, 2017, Resverlogix [...]

House and Senate Agree: Palliative Care Matters!

12/12/2017 - 23:30

Surrey, BC, Canada, Dec. 12, 2017 (GLOBE NEWSWIRE) -- (Dec 12, 2017) In a time when House and Senate don’t always agree – it is refreshing that both groups voted “yes” to federal legislation to develop a framework for [...]

Dentsply Sirona Declares Quarterly Cash Dividend

12/12/2017 - 23:00

YORK, Pa., Dec. 12, 2017 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (NASDAQ: XRAY ), The Dental Solutions Company TM , announced that its Board of Directors declared a quarterly cash dividend of $0. [...]

Telix Pharmaceuticals and JFE Announce Japanese Radiopharmaceutical Manufacturing Partnership

12/12/2017 - 23:00

MELBOURNE, Australia and TOKYO, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) (“ Telix ”, the “ Company ”), an Australian biopharmaceutical company focused on the development of diagnostic [...]